|Basic InformationMore InformationTestsLatest News|Antidepressants Used by 12.7 Percent of Those Age ≥12 in U.S.U.S. Antidepressant Use Jumps 65 Percent in 15 YearsSmoking During Pregnancy Up Among Women With DepressionDepression After Coronary Artery Disease Diagnosis Ups Death RiskYoga May Help Ease DepressionLonger Estrogen Exposure May Protect Against DepressionEstrogen May Influence Women's Depression RiskLosing Medicaid Tough on People Battling Depression: StudyAddition of Aripiprazole Ups Major Depressive Disorder RemissionNo Sign That Antidepressants in Pregnancy Harm Kids' Brains: StudyMed Switch Not Always Best Choice With Tough DepressionDepression Contributes to Health Decline Seen in Cancer CaregiversDepression May Worsen Health for Cancer CaregiversElectric Brain Stimulation No Better Than Meds For Depression: StudyDepression Inversely Linked to Body Composition in TeensReview: Depression Screening As Inpatient Important, FeasibleDepression Can Slow Hospital Patients' Recovery: StudyAntidepressants During Pregnancy Safe for Baby: StudyWhat You Need to Know About AntidepressantsAPA: Internet-Based CBT Can Be Helpful in DepressionCan Online Treatment Replace Your Therapist?Depression Often a Precursor to Falls in Elderly PeopleObesity, Sex Predict Remission for Antidepressant MedicationsGender Differences in Depression Tend to Appear About Age 12Depression's Gender Gap Shows Up in Pre-Teen YearsStudies Question Link Between Mom's Antidepressant Use, Autism in KidsTrauma as a Teen May Boost Depression Risk Around MenopauseBlood Test Promising for ID of Early Depression, SchizophreniaBlood Test Might Someday Distinguish Early Depression, SchizophreniaHold That Pose: Yoga May Ease Tough DepressionDepression May Hasten Death in Years After Heart DiagnosisAntidepressant Efficacy Varies for Depressive Symptom ClustersDepressed Psoriasis Patients at Higher Risk of Psoriatic ArthritisCan Depression Up Odds for Arthritis Linked to Psoriasis?Postpartum Depressive Symptoms Fell in 2004 to 2012Depression Often Untreated in Dialysis PatientsPostpartum Depression Affects New Dads, TooPanic Disorder May Up Odds of Depression Rx Side EffectsSometimes the Holidays Aren't Always JollyPilots Suffer Depression, Suicidal Thoughts at Fairly High RatesMore Than 1 in 10 Pilots Suffer From Depression, Survey FindsSelf-Care Tools Cut Depression in AMD, Diabetic RetinopathyDepression, Suicide Ideation Prevalent in Medical StudentsDepression on the Rise Among U.S. Teens, Especially GirlsDepressive Symptoms Linked to Functional Status in CADHigh Rate of Antidepressant Use After CancerResearchers Find Antidepressant Bupropion Crosses PlacentaMom-to-Be's Antidepressant Use May Be Tied to Speech Issues in ChildDepression Can Fuel Heart Disease in Midlife Women: StudyDepression Common in Patients With Chronic AnginaQuestions and AnswersVideosLinksBook Reviews
Antidepressant Efficacy Varies for Depressive Symptom Clusters
Updated: Feb 28th 2017
TUESDAY, Feb. 28, 2017 (HealthDay News) -- Antidepressant treatment efficacy varies for empirically-defined clusters of symptoms, according to a study published online Feb. 22 in JAMA Psychiatry.
Adam M. Chekroud, from Yale University in New Haven, Conn., and colleagues determined the efficacy of antidepressant treatments on empirically defined groups of symptoms. Data on patients with depression from the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) trial were used to identify clusters of symptoms. These findings were replicated using the Combining Medications to Enhance Depression Outcomes (CO-MED) trial. Using intent-to-treat data for the 4,706 patients from both trials, the authors examined whether observed symptom clusters have differential response trajectories; data were also included for 2,515 additional placebo and active-comparator phase 3 trials of duloxetine.
The researchers found that at baseline, there were three symptom clusters identified in the self-reported Quick Inventory of Depressive Symptomatology scale in STAR*D, which was replicated in CO-MED and was similar for the clinician-rated Hamilton Depression rating scale. Eight of nine antidepressants were more effective for core emotional symptoms than for sleep or atypical symptoms. Between-drug differences in efficacy were often greater than the difference between treatments and placebo.
"Selecting the best drug for a given cluster may have a bigger benefit than that gained by use of an active compound versus a placebo," the authors write.
Several authors disclosed financial ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
This article: Copyright © 2017 HealthDay. All rights reserved.